返回
Fujian Haixi Pharmaceuticals Co., Ltd.（02637.HK）價格
02637.HK 股價走勢圖
HAIXI PHARMA (02637.HK)
Fujian Haixi Pharmaceuticals Co., Ltd.
HK$151.2
-2.89%
$-4.5
休市： Jan 20, 16:00:00 HKT
關鍵數據
前收市價
$155.6
開盤價
$155.7
當日範圍
$150 - $157.4
52週區間
$97.5 - $151.2
交易量
46.5K
平均成交量
140.1K
每股盈餘 (TTM)
--
股息收益率
--
市值
$11.9B
什麼是 HAIXI PHARMA？
Fujian Haixi New Drug Creation Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Fuzhou, Fujian. The company went IPO on 2025-10-20. The Company’s main products include Anbili, Haihuitong, Ruiantuo and Saixifu. The Company’s products are mainly used in digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases, inflammatory diseases, oncology, ophthalmology, respiratory diseases and others. The firm mainly operates its businesses in the domestic market.